openPR Logo
Press release

BARDA, NIH and Janssen to Present on Antimicrobial Resistance at Superbugs USA this Autumn

06-28-2016 04:12 PM CET | Health & Medicine

Press release from: SMi Group

BARDA, NIH and Janssen to Present on Antimicrobial Resistance

SMi are delighted to announce the expansion of their antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA, complementing the Group’s Superbugs & Superdrugs European conference which has been running for the past 18 years.

With pending confirmations from PAHO/WHO and Astra Zeneca, SMi Group have worked closely with a panel of speakers to present an agenda that will look to address key issues surrounding funding opportunities and US national plans, multi resistance gram negative infections, novel protein based biologics and antimicrobial drug development.

Some of those who have confirmed to speak include:
• Dr Christopher Houchens, Branch Chief, Antibacterial's Program, BARDA
• Dr Rosemarie Aurigemma, Chief, Biodefense Drug Development Section , NIH
• Dr Anthony Simon Lynch, Senior Scientific Director, Janssen Research & Development LLC
• Dr Alita Miller, Director of Biology, Entasis Therapeutics
• William J Weiss, Director, Pre-Clinical Services, UNT Health Science Center
• Dr Domingo Gargallo-Viola, Co-Founder and CSO, ABAC Therapeutics
• Dr David Cook, Chief Scientific Officer, Blueberry Therapeutics Ltd

An agenda and full speaker line-up is expected to be released within the next few weeks.

Further information is available at http://www.superbugs-usa.com/openpr

Superbugs & Superdrugs USA
November 14th & 15th 2016
Renaissance Woodbridge Hotel, Iselin, New Jersey

---END---

Contact Information:

For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
To register for the conference, visit http://www.superbugs-usa.com or contact Matthew Apps on Tel: +44 (0)20 7827 6093 / Email: mapps@smi-online.co.uk
To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

SMi Group Ltd, 2nd Floor South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, United Kingdom, Link to Map
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BARDA, NIH and Janssen to Present on Antimicrobial Resistance at Superbugs USA this Autumn here

News-ID: 346212 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for BARDA

Psychotherapeutics Drugs Market Global Research and Clinical Survey Report 2020
The Psychotherapeutics Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Get Sample Copy of this
The Key to Understanding Donald J. Trump - By Kobby Barda
Genre: Nonfiction / Biography & Autobiography / Presidents & Heads Of State Subject: Presidency of Donald Trump ISBN: 978-965-92788-2-4 ASIN: B082HSZ4DH (Digital) Page Count: 281 Publish Date: December 10, 2019 Soft Cover Book: 7.99 (http://bit.ly/2EIJYFL), EBook/Kindle: 3.99 (https://www.amazon.com/-/he/gp/product/B082HSZ4DH?pf_rd_p=a1c204f1-1179-41d8-ab42-98f2b281752e&pf_rd_r=K5VC1XZJ2AZBGJRWYX9K) ABOUT THE BOOK ”To understand the logic of chaos” The book “The Key to Understanding Donald J. Trump” tries to get beyond the smokescreen, and to understand the behavior of Donald Trump, which sometimes seems to elusive -
SMi’s Exclusive Interview with Mark Albrecht has been released
SMi Reports: An exclusive interview with Biomedical Advanced Research and Development Authority (BARDA) acting Chief Mark Albrecht has been released in the run-up to the 3rd annual Superbugs & Superdrugs USA Conference taking place in Iselin, New Jersey on November 12 - 13, 2018. Mark provided us with some insightful content about his role in the field, his view on challenges within the field and his vision on the future of
2017 Agenda Released for Superbugs USA Featuring Talks from BARDA, CARB-X, Pfize …
Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group are thrilled to announce the return of Superbugs and Superdrugs USA which arrives to Iselin, New Jersey on November 13th & 14th 2017. Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases, innovation and collaboration is requested at
Agenda released for SMi’s 19th Annual Superbugs European Show Featuring Keynot …
Following on from what is set to be a successful Superbugs USA summit in two weeks’ time, SMi Group is delighted to release an agenda for its 19th annual Superbugs & Superdrugs European conference which returns to Central London on 20th and 21st March 2017. London’s flagship show in the global Superbugs portfolio of events has been expanding horizons on the growing threat of anti-microbial resistance (AMR) and infectious disease for
Interviews Released on Antibiotic Resistance with BARDA, Janssen and Blueberry T …
SMi Group release an exclusive series of interviews ahead of the Superbugs & Superdrugs USA Conference that will take place on Nov 14th and 15th. Running for 18 years in Europe, SMi Group's Superbugs & Superdrugs event will travel across the Atlantic Ocean for the first time to Iselin New Jersey following a high attendance of US delegates at the European show. The popularity of the event highlights the imminent